Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes
Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a…
February 23, 2018 - 3 minutes
Intarcia
Swiss-US Partners Reveal New Candidate for Autoimmune Disease
Numab and Intarcia have a first candidate to combine a tri-specific antibody fragment with a…
September 15, 2017 - 2 minutes
Fresh Cash for a Device that Can Treat Diabetes and Prevent HIV
Intarcia will develop a drug delivery device for HIV prevention that can significantly reduce dosing…
January 2, 2017 - 2 minutes
Could this be the ‘Beginning of the end’ for Diabetes? Let’s Review.
Given the rates of diabetes reaching 'epidemic proportions', we figured it was time to have…
June 14, 2016 - 9 minutes
Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases
Numab and Intarcia have achieved key milestones in the development of therapeutic antibody fragments. This…
June 6, 2016 - 2 minutes
Servier to revolutionize Diabetes treatment thanks to Intarcia’s successful Phase III
Treatment of diabetes hasn't changed so much since the development of first human insulin by…
September 18, 2015 - 3 minutes
Review: The Future of Biomarkers in Immuno-Oncology
Immuno-oncology is a Biotech field that is more than just hype - it could solve…
August 31, 2015 - 5 minutes
Why do Servier bets one Billion euros on Revolutionary Diabetes Drugs Delivery Device?
The French company Servier wants to invest one billion euros by a partnering with the…
November 15, 2014 - 2 minutes
